feed,title,long_url,short_url
Benzinga,"The Week Ahead In Biotech: Takeda, Blueprint Medicines, Orphazyme, Eton On The Radar Ahead of FDA Decisions, IPOs",https://benzinga.com/general/biotech/21/06/21533636/the-week-ahead-in-biotech-takeda-blueprint-medicines-orphazyme-eton-on-the-radar-ahead-of-fda-dec,https://j.mp/2Sv3pfy
